Association of Clinical Research Professionals (ACRP) Certified Professional Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the ACRP Certified Professional Exam with our comprehensive quiz. Elevate your clinical research skills with targeted flashcards and multiple-choice questions. Enhance your readiness with detailed explanations and insights for improved performance!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

An important goal during the early trials is to determine which of the following?

Patient enrollment strategies
Market potential of the drug
Safe duration of drug exposure
Cost of development

The correct answer is: Safe duration of drug exposure

In the early trials of a drug, it is crucial to focus on establishing the safety profile of the drug, including understanding the safe duration of drug exposure. This involves assessing how long patients can be safely exposed to the drug without experiencing adverse effects or toxicity. Determining the safe duration is vital for developing treatment regimens, ensuring patient safety, and complying with regulatory requirements. While other aspects, such as patient enrollment strategies, market potential, and development costs, are important factors in the overall drug development process, the primary concern during early trials is confirming that the drug can be administered safely to participants over a defined period. Understanding the safety duration helps guide further clinical trial phases and the decision-making process for continuing development.